Capillus to Attend the American Academy of Dermatology’s Annual Meeting in San Diego
MIAMI (PRWEB) February 16, 2018 -- Capillus, LLC will be exhibiting during the American Academy of Dermatology’s 2018 AAD Annual Meeting, which is taking place at the San Diego Convention Center in San Diego, California from February 16th – 20th, 2018. Capillus will be located in Booth #3729 in the main aisle of the convention center’s exhibition hall.
Visitors to their booth will be able to see a demonstration of their complete line of laser therapy devices for in-office and at-home treatment that are FDA-cleared and clinically proven to help prevent hair loss and promote hair regrowth. Their full-line of laser therapy devices includes the CapillusRX™, which contains more lasers than any low-level laser therapy device in the market for home treatment of hair loss. It has 312 diodes provide maximum simultaneous coverage of the scalp, and it is available only through the Capillus physician network.
In addition to the CapillusRX™, Capillus offers three other FDA-Cleared laser caps for direct sale via http://www.capillus.com: 1) Capillus82™, an economical and convenient device with 82 laser diodes, 2) Capillus202™, a powerful yet affordable device containing 202 laser diodes, and the 3) CapillusPro ™, a professional-grade device with 272 laser diodes. For in-office laser treatments, Capillus also offers the Capillus OfficePro™ , which is available to physicians and salons only.
Capillus laser therapy devices use low-level laser therapy (LLLT), which is a non-invasive and chemical-free medical treatment for hair loss. The Capillus laser therapy caps use a six-minute protocol, which greatly reduces the time it takes to receive treatment. And they can be used in combination with any other hair restoration treatment method including hair transplants.
The company will also showcase its recently rebranded Cap+ line of clinical hair care products, which use the best ingredients to gently cleanse, exfoliate, and moisturize hair to promote overall scalp health, along with the RXCap+ Extra Strength 5% Minoxidil, which has been shown to regrow hair in men, and its line of Cap+ Keratin Hair Fibers that provide a temporary quick fix for instant coverage in seconds.
Physicians interested in learning how low-level laser therapy can help patients suffering from androgenetic alopecia are urged to stop by the Capillus booth and meet with the Capillus team. Physicians visiting the Capillus exhibit (booth #3729) will be able to register for a chance to win a CapillusPro™ (valued at $3,000). The winner will be announced on Sunday, February 18th, 2018.
Leading the Capillus team is Carlos Piña, Chief Executive Officer and Founder. Accompanying Carlos will be Maria Piña, Chief Operating Officer, Frances Brea, Chief Marketing Officer, and the Capillus client relations team composed of: Fernando Bermudez, Director of Business Development, Felix Perez, Account Executive/Physicians Relations, Carly Klein, Account Executive/Physician Relations, Barry Pintar, Account Executive/Physician Relations. Each team member has years of experience in the hair care and restoration field, along with Lisa Weaver, International Distribution Director, who has extensive experience in the beauty industry.
About Capillus, LLC
Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premier product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health under the Cap+ and RXCap+ brand. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.
For more information visit https://www.capillus.com.
FRANCES PINA-BREA, Capillus, LLC, https://www.capillus.com, +1 +1 (786) 888-1875 x 102, [email protected]
Share this article